To determine the difference in time to recovery and healing of monkey pox lesions between people receiving Tecovirimat and those receiving placebo. People with severe cases of monkeypox will receive Tecovirimat and not placebo.
Principal Investigator
Thomas Patterson
Irma Scholler
210-450-3150
scholler@uthscsa.edu
Illness < 14 days before study entry, have at least 1 active (not scabbed) lesion
Illness < 14 days before study entry, have at least 1 active (not scabbed) lesion